September 19, 2014 1:37 PM ET

Pharmaceuticals

Company Overview of Avion Pharmaceuticals, LLC

Company Overview

Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, develops and markets a portfolio of pharmaceutical and dietary supplement products in the women’s heath and dermatology therapeutic areas. It offers Prenate, which improves the nutritional status of women throughout pregnancy and in the postnatal period for lactating and non-lactating mothers; Nicomide, which contains niacin, zinc, and folic acid, and addresses the inflammatory response before acne lesions; and PRENATE MINI, a blended vitamin incorporating QUATREFOLIC, DHA, 13 vitamins and minerals, and 25mg of blueberry extract. The company also provides PRENATE DHA, a blended vitamin incorporating QUATREFOLIC, DHA, and 8 vitam...

8505 Dunwoody Place

Atlanta, GA 30350

United States

Founded in 2010

Phone:

888-612-8466

Fax:

678-746-0717

Key Executives for Avion Pharmaceuticals, LLC

Chief Executive Officer
Chief Operation Officer
Compensation as of Fiscal Year 2014.

Avion Pharmaceuticals, LLC Key Developments

Avion Pharmaceuticals, LLC Presents at Jefferies 2014 Global Healthcare Conference, Jun-02-2014 10:30 AM

Avion Pharmaceuticals, LLC Presents at Jefferies 2014 Global Healthcare Conference, Jun-02-2014 10:30 AM. Venue: Grand Hyatt, New York, New York, United States. Speakers: Michael Sullivan, President.

Avion Pharmaceuticals, LLC Appoints Mike Sullivan as President

Avion Pharmaceuticals, LLC announced the promotion of Mike Sullivan to the position of President. Sullivan joined Avion Pharmaceuticals in 2011 as Vice President of Sales and Marketing. Tapped for his expertise in building corporate start-up pharmaceutical organizations, he has been instrumental in the commercial development, infrastructure and successful launch of Avion over the past three years.

Avion Pharmaceuticals LLC Launches Prenate Enhance and Prenate Restore

Avion Pharmaceuticals LLC announced the launch of two advanced vitamin formulations as the newest additions to the Prenate Vitamin Family. Prenate Enhance and Prenate Restore have been designed to support important nutritional supplementation for women during their prenatal and postpartum period, as well as provide the optimal level of vitamins and minerals recommended. Prenate Enhance and Prenate Restore are advanced prescription dietary supplements designed for enhanced absorption with ingredients selected for their high absorbability. Prenate Enhance and Prenate Restore provide the higher DHA content (400 mg) among leading prescription prenatal and postnatal vitamins. Prenate Enhance and Restore also include Formical(R) (calcium formate), a patented form of calcium that is better absorbed than calcium citrate and calcium carbonate. Both products provide proprietary Quatrefolic(R), a source of folate that is approximately seven times more bioavailable than folic acid. Prenate Restore, the first prescription postnatal dietary supplement with probiotics, designed for postpartum supplementation, helps support the needs of both moms.

Similar Private Companies By Industry

Company Name Region
QR Pharma, Inc. United States
AlphaCore Pharma LLC United States
Prometrika, LLC United States
H. Bana Ltd. United States
Xel Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Avion Pharmaceuticals, LLC, please visit www.avionrx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.